Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.

Ahmed M, Eeles R.

Future Sci OA. 2015 Dec 18;2(1):FSO87. doi: 10.4155/fso.15.87. eCollection 2016 Mar. Review.

2.

Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer.

Babaei F, Ahmadi A, Rezaei F, Jalilvand S, Ghavami N, Mahmoudi M, Abiri R, Kondori N, Nategh R, Mokhtari Azad T.

Iran Red Crescent Med J. 2015 Dec 19;17(12):e19439. doi: 10.5812/ircmj.19439. eCollection 2015 Dec.

3.

A Perspective on Prostate Carcinogenesis and Chemoprevention.

Bosland MC, Ozten N, Eskra JN, Mahmoud AM.

Curr Pharmacol Rep. 2015 Aug 1;1(4):258-265. Epub 2015 Apr 11.

4.

The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria.

Agalliu I, Adebiyi AO, Lounsbury DW, Popoola O, Jinadu K, Amodu O, Paul S, Adedimeji A, Asuzu C, Asuzu M, Ogunbiyi OJ, Rohan T, Shittu OB.

BMC Public Health. 2015 Apr 26;15:425. doi: 10.1186/s12889-015-1754-x.

5.

Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.

Wright ME, Albanes D, Moser AB, Weinstein SJ, Snyder K, Männistö S, Gann PH.

Cancer Med. 2014 Dec;3(6):1562-9. doi: 10.1002/cam4.319. Epub 2014 Aug 16.

6.

Shared common variants in prostate cancer and blood lipids.

Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F; PRACTICAL Consortium; CRUK GWAS, Djurovic S, Desikan RS, Mills IG, Dale AM.

Int J Epidemiol. 2014 Aug;43(4):1205-14. doi: 10.1093/ije/dyu090. Epub 2014 Apr 30.

7.

Potential role of gastrointestinal microbiota composition in prostate cancer risk.

Amirian ES, Petrosino JF, Ajami NJ, Liu Y, Mims MP, Scheurer ME.

Infect Agent Cancer. 2013 Nov 4;8(1):42. doi: 10.1186/1750-9378-8-42.

8.

Choline intake and risk of lethal prostate cancer: incidence and survival.

Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan JM.

Am J Clin Nutr. 2012 Oct;96(4):855-63. Epub 2012 Sep 5.

9.

Dietary calcium and risk for prostate cancer: a case-control study among US veterans.

Williams CD, Whitley BM, Hoyo C, Grant DJ, Schwartz GG, Presti JC Jr, Iraggi JD, Newman KA, Gerber L, Taylor LA, McKeever MG, Freedland SJ.

Prev Chronic Dis. 2012;9:E39. Epub 2012 Jan 12.

10.

Estimated phytanic acid intake and prostate cancer risk: a prospective cohort study.

Wright ME, Bowen P, Virtamo J, Albanes D, Gann PH.

Int J Cancer. 2012 Sep 15;131(6):1396-406. doi: 10.1002/ijc.27372. Epub 2012 Jan 24.

11.

Adolescent dairy product consumption and risk of type 2 diabetes in middle-aged women.

Malik VS, Sun Q, van Dam RM, Rimm EB, Willett WC, Rosner B, Hu FB.

Am J Clin Nutr. 2011 Sep;94(3):854-61. doi: 10.3945/ajcn.110.009621. Epub 2011 Jul 13.

12.

An update analysis of two polymorphisms in encoding ribonuclease L gene and prostate cancer risk: involving 13,372 cases and 11,953 controls.

Mi YY, Zhu LJ, Wu S, Feng NH.

Genes Nutr. 2011 Nov;6(4):397-402. doi: 10.1007/s12263-011-0221-2. Epub 2011 Apr 17.

13.

Dietary intake of micronutrients and the risk of developing bladder cancer: results from the Belgian case-control study on bladder cancer risk.

Brinkman MT, Buntinx F, Kellen E, Dagnelie PC, Van Dongen MC, Muls E, Zeegers MP.

Cancer Causes Control. 2011 Mar;22(3):469-78. doi: 10.1007/s10552-010-9718-z. Epub 2011 Jan 4.

14.

AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.

Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL.

Prostate. 2011 Apr;71(5):498-506. doi: 10.1002/pros.21267. Epub 2010 Oct 13.

15.

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM.

Am J Epidemiol. 2010 Sep 1;172(5):566-77. doi: 10.1093/aje/kwq148. Epub 2010 Aug 6.

16.

Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjønneland A, Olsen A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Vineis P, Palli D, Tumino R, Sieri S, Bueno-de-Mesquita HB, van Duijnhoven FJ, Chirlaque MD, Barricarte A, Larrañaga N, González CA, Argüelles MV, Sánchez MJ, Stattin P, Hallmans G, Khaw KT, Bingham S, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

Am J Epidemiol. 2009 May 15;169(10):1223-32. doi: 10.1093/aje/kwp022. Epub 2009 Apr 9.

17.

The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study.

Farhat GN, Taioli E, Cauley JA, Zmuda JM, Orwoll E, Bauer DC, Wilt TJ, Hoffman AR, Beer TM, Shikany JM, Daniels N, Chan J, Fink HA, Barrett-Connor E, Parsons JK, Bunker CH; Osteoporotic Fractures in Men (MrOS) Study Group.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):148-54. doi: 10.1158/1055-9965.EPI-08-0415.

18.

Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer Cells.

Aalinkeel R, Hu Z, Nair BB, Sykes DE, Reynolds JL, Mahajan SD, Schwartz SA.

Evid Based Complement Alternat Med. 2010 Jun;7(2):177-87. doi: 10.1093/ecam/nem184. Epub 2008 Jan 10.

19.

Dietary habits and prostate cancer detection: a case-control study.

Amin M, Jeyaganth S, Fahmy N, Bégin LR, Aronson S, Jacobson S, Tanguay S, Kassouf W, Aprikian A.

Can Urol Assoc J. 2008 Oct;2(5):510-5.

20.

Biological mediators of effect of diet and stress reduction on prostate cancer.

Saxe GA, Major JM, Westerberg L, Khandrika S, Downs TM.

Integr Cancer Ther. 2008 Sep;7(3):130-8. doi: 10.1177/1534735408322849.

Supplemental Content

Support Center